Yves Berthiaume

Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications

Morally Problematic Situations Encountered by Adults Living With Rare Diseases.

Morally Problematic Situations Encountered by Adults Living With Rare Diseases.

Journal: AJOB empirical bioethics
Published: December 14, 2023

Understanding Rare Disease Experiences Through the Concept of Morally Problematic Situations.

Understanding Rare Disease Experiences Through the Concept of Morally Problematic Situations.

Journal: HEC forum : an interdisciplinary journal on hospitals' ethical and legal issues
Published: June 30, 2023

An Ethics Action Plan for Rare Disease Care: Participatory Action Research Approach.

An Ethics Action Plan for Rare Disease Care: Participatory Action Research Approach.

Journal: Journal of participatory medicine
Published: February 21, 2023

Association of low-density neutrophils with lung function and disease progression in adult cystic fibrosis.

Association of low-density neutrophils with lung function and disease progression in adult cystic fibrosis.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: October 21, 2022

Genetic evidence supports the development of SLC26A9 targeting therapies for the treatment of lung disease.

Genetic evidence supports the development of SLC26A9 targeting therapies for the treatment of lung disease.

Journal: NPJ genomic medicine
Published: December 30, 2021

Correction to: Cystic fibrosis-related diabetes onset can be predicted using biomarkers measured at birth.

Correction to: Cystic fibrosis-related diabetes onset can be predicted using biomarkers measured at birth.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: August 14, 2021

Peripheral blood mononuclear cell response to YKL-40 and Galectin-3 in cystic fibrosis.

Peripheral blood mononuclear cell response to YKL-40 and Galectin-3 in cystic fibrosis.

Journal: Cytokine
Published: March 10, 2021

Impact of ENaC downregulation in transgenic mice on the outcomes of acute lung injury induced by bleomycin.

Impact of ENaC downregulation in transgenic mice on the outcomes of acute lung injury induced by bleomycin.

Journal: Experimental physiology
Published: September 08, 2020

YKL-40 as a clinical biomarker in adult patients with CF: Implications of a CHI3L1 single nucleotide polymorphism in disease severity.

YKL-40 as a clinical biomarker in adult patients with CF: Implications of a CHI3L1 single nucleotide polymorphism in disease severity.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: August 20, 2020

Cystic fibrosis-related diabetes onset can be predicted using biomarkers measured at birth.

Cystic fibrosis-related diabetes onset can be predicted using biomarkers measured at birth.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: July 22, 2020

Efficient Transcriptionally Controlled Plasmid Expression System for Investigation of the Stability of mRNA Transcripts in Primary Alveolar Epithelial Cells.

Efficient Transcriptionally Controlled Plasmid Expression System for Investigation of the Stability of mRNA Transcripts in Primary Alveolar Epithelial Cells.

Journal: Journal of visualized experiments : JoVE
Published: March 24, 2020

Impact of Bacterial Toxins in the Lungs.

Impact of Bacterial Toxins in the Lungs.

Journal: Toxins
Published: February 27, 2020
Showing 1-12 of 55

Last Updated: 09/26/2026